Taslim Ahmed Al-Hilal

This study demonstrates that FOLR1-targeted Actinium-225 alpha-particle therapy effectively treats ovarian cancer with high tumor regression and survival rates while minimizing toxicity.

This study identifies MCM10 as a potential biomarker for CRC disparities in Hispanics by analyzing stress-survival pathway gene expression and functional roles in tumor progression.

This paper identifies Doppel as a specific biomarker for ovarian cancer, showing its association with tumor subtypes, early detection, and dissemination mechanisms.

This study identifies TAT1-mediated microtubule acetylation as a key regulator of fibroblast durotaxis and fibrosis across multiple organs.